Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
BACKGROUND: The target enzyme of pyrimethamine is dihydrofolate reductase (DHFR), but little is known about allelic variants of dhfr in Plasmodium vivax populations. Still less is known about associations between specific alleles and the failure of sulfadoxine/pyrimethamine (S/P) to clear the eryth...
المؤلفون الرئيسيون: | Hastings, MD, Porter, K, Maguire, J, Susanti, I, Kania, W, Bangs, M, Sibley, C, Baird, J |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2004
|
مواد مشابهة
-
Effects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamine.
حسب: David J Bacon, وآخرون
منشور في: (2009-08-01) -
Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa.
حسب: Ochong, E, وآخرون
منشور في: (2003) -
Multiple origins of resistance-conferring mutations in <it>Plasmodium vivax dihydrofolate reductase</it>
حسب: O'Neil Michael T, وآخرون
منشور في: (2008-04-01) -
Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
حسب: Imwong, M, وآخرون
منشور في: (2001) -
Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia.
حسب: Lederman, E, وآخرون
منشور في: (2006)